Diagnostics

Skin cholesterol consumer products may help determine heart disease risk

Published in Drug Week, November 15th, 2002

IMI International Medical Innovations, Inc., (TSX:IMI) initiated its first clinical study involving consumer products for risk assessment of coronary artery disease through skin cholesterol.

A professional point-of-care skin cholesterol test system, IMI's Cholesterol 1,2,3 is cleared for sale in the U.S., Europe, and Canada.

In the trial IMI is evaluating two different products that were developed with input from the company's Canadian marketing partner, McNeil Consumer Healthcare. Both tests feature a simplified test procedure suitable for the consumer market. One test design involves placing the fingertip on a test strip that changes color to...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Week

Source: Drug Week (2002-11-15)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry